(Q28258687)

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Point: hyperbaric oxygen is beneficial for diabetic foot wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Successful treatment of brainstem abscess with stereotactic aspiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

21 January 2018

Anaerobic infections. 1.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Susceptibility of anaerobic bacteria to 23 antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Emergence of beta-lactamase producing anaerobic bacteria in the tonsils during penicillin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Susceptibility of respiratory tract anaerobes to orally administered penicillins and cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Anaerobic isolates in chronic recurrent suppurative otitis media. Treatment with carbenicillin alone and in combination with gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

In vitro activity of penicillins against anaerobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Recent taxonomic changes and terminology update of clinically significant anaerobic gram-negative bacteria (excluding spirochetes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Intra-abdominal, retroperitoneal, and visceral abscesses in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Two decades of imipenem therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Carbapenems and monobactams: imipenem, meropenem, and aztreonam

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Meropenem: a microbiological overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Activity of meropenem against antibiotic-resistant or infrequently encountered gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Ertapenem: a review of its use in the treatment of bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Clindamycin, metronidazole, and chloramphenicol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Chloramphenicol: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Presence and antibiotic resistance of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Clinical pharmacokinetics of antibacterial drugs in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Clostridium difficile--Associated diarrhea: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Clindamycin in Treatment of Aspiration Pneumonia in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Clindamycin in dentistry: more than just effective prophylaxis for endocarditis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Susceptibility of Anaerobic Bacteria to Metronidazole: Relative Resistance of Non-Spore-Forming Gram-Positive Baccilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Metronidazole. A therapeutic review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Lack of evidence for cancer due to use of metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Therapy of mixed anaerobic-aerobic infections. Lessons from studies of intra-abdominal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Safety of metronidazole during pregnancy: a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Tigecycline: a new glycylcycline antimicrobial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Fluoroquinolones and anaerobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Pathogenesis and management of polymicrobial infections due to aerobic and anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Empiric treatment of nosocomial intra-abdominal infections: a focus on the carbapenems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Decision-making analysis for selection of antibiotic treatment in intra-abdominal infection using preference measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Continuous infusion of ticarcillin-clavulanate for home treatment of serious infections: clinical efficacy, safety, pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Antibiotic synergy and antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Combined activity of clindamycin and gentamicin on Bacteroides fragilis and other bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Interaction between penicillin, clindamycin or metronidazole and gentamicin against species of clostridia and anaerobic and facultatively anaerobic gram-positive cocci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

Quinolone activity against anaerobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.6.991

21 January 2018

Identifiers

DOI

10.1586/14787210.5.6.991

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

18039083

1 reference

Consolidated OpenCitations Corpus – April 2017